Canakinumab: A comprehensive look at its potential side effects

Canakinumab (Canakinumab), as a biological agent targeting specific inflammatory diseases, has demonstrated significant efficacy in clinical treatment in recent years. However, like all medications, the use of canakinumab comes with a range of potential side effects, the severity and frequency of which vary among individuals.

Some of the most common side effects patients may experience while taking canakinumab. These include cold or flu-like symptoms such as runny nose, cough, sore throat and body aches, which are usually mild and short-lived. Additionally, the digestive system may be affected, causing nausea, vomiting, diarrhea, or stomach pain. Some patients may also experience painful urination, dizziness with a spinning sensation, and headaches. Weight gain and itching, redness, swelling, or warmth at the injection site are also common reactions.

However, canakinumab may also cause some serious side effects, which require patients and doctors to be highly vigilant. People who are allergic to canakinumab may develop a severe allergic reaction, with symptoms including nausea, difficulty swallowing, dizziness, fast or pounding heartbeat, difficulty breathing, and swelling of the face, lips, tongue, or throat. These allergic reactions can be life-threatening, so seek emergency medical help as soon as symptoms occur.

Patients may also be at risk for serious or fatal infections during treatment with canakinumab. Signs of infection include fever, chills, sweating that lasts for more than 3 days, pain, heat, or swelling in any part of the body, as well as stomach pain, diarrhea, and weight loss. Additionally, a persistent cough, shortness of breath, chest pain, coughing up mucus or blood, pain or burning when urinating, and redness, warm, red, or swollen parts of the body may also be signs of infection. Flu symptoms accompanied by extreme fatigue should also be cause for concern.

It is important to note that the side effects listed above are not exhaustive and other side effects not mentioned may also occur during treatment with canakinumab. Therefore, when receiving canakinumab treatment, patients should fully understand and pay close attention to their own reactions, and communicate with their doctors regularly so that the treatment plan can be adjusted in a timely manner and any discomfort can be dealt with. At the same time, doctors should also weigh the pros and cons and formulate a reasonable treatment plan based on the patient's specific situation.

Reference materials:https://www.drugs.com/search.php?searchterm=ILARIS&sources%5B%5D=professional